MASCC

Agenda: • Introduction – Prof Maryam Lustberg • Set the Scene: How to Determine the Optimized Treatment for Early-Stage Hormone Receptor Positive Breast Cancer – Dr Kevin Kalinsky • Personalized Precision Medicine and Supportive Care in Cancer – Dr Ines Vaz-Duarte-Luis • How to Improve Adherence – Dr Dawn Hershman • Patient Experience – Closing the Loop – Stacey Tinianov (Patient Partner) Objectives: • Increase awareness of how to best utilize Oncotype DX testing in various clinical scenarios • Improve the understanding of 21 gene recurrence assay to optimize clinical care and outcomes of patients with cancer • Discuss how to offer personalize symptom management for patients experiencing endocrine therapy and chemotherapy toxicity as part of their personalized treatment recommendation from Oncotype Dx testing Learner Outcomes: • Have an improved understanding of molecular profiling improves breast cancer care by yielding personalized medicine approaches that tailor both treatment and helps mitigate unnecessary toxicities